Biotech Values

[biomaven0]

he specificity of only 87% is problematic

I disagree with you here. Let's assume I could come up with a test that was only 50% specific, but close to 100% sensitive for polyps. Use of that test would cut the need for colonoscopies in half and greatly improve the overall testing system.

This is a very different application from those like prostate or breast cancer screening where a false-positive leads to a biopsy. Here the false positive simply leads to the same procedure you would have done anyway absent the test.

So the big disappointment for me (and it's personal given I am due a colonoscopy in the next year or two) is the low 42% sensitivity.

Peter